• Fervent Pharmaceuticals to Begin Menopause Therapy Trial americanpharmaceuticalreview
    December 29, 2017
    Fervent Pharmaceuticals has submitted an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) for FP-101, its proprietary lead drug candidate for treating menopause symptoms, especially hot flashes.
PharmaSources Customer Service